Search

Ching Chang

Examiner (ID: 3427, Phone: (571)272-4857 , Office: P/3748 )

Most Active Art Unit
3748
Art Unit(s)
3748, 3746
Total Applications
1871
Issued Applications
1700
Pending Applications
11
Abandoned Applications
170

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5585073 [patent_doc_number] => 20090104275 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'Nanoencapsulation of Proteins' [patent_app_type] => utility [patent_app_number] => 11/563012 [patent_app_country] => US [patent_app_date] => 2006-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 271 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20090104275.pdf [firstpage_image] =>[orig_patent_app_number] => 11563012 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/563012
Nanoencapsulation of Proteins Nov 22, 2006 Abandoned
Array ( [id] => 5625872 [patent_doc_number] => 20060264377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Chemically modified novel erythropoietin stimulating protein compositions and methods' [patent_app_type] => utility [patent_app_number] => 11/498358 [patent_app_country] => US [patent_app_date] => 2006-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 6874 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20060264377.pdf [firstpage_image] =>[orig_patent_app_number] => 11498358 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/498358
Chemically modified novel erythropoietin stimulating protein compositions and methods Aug 1, 2006 Abandoned
Array ( [id] => 5760661 [patent_doc_number] => 20060211606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Peptides' [patent_app_type] => utility [patent_app_number] => 11/378624 [patent_app_country] => US [patent_app_date] => 2006-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 18890 [patent_no_of_claims] => 100 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20060211606.pdf [firstpage_image] =>[orig_patent_app_number] => 11378624 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/378624
Peptides Mar 19, 2006 Abandoned
Array ( [id] => 5095540 [patent_doc_number] => 20070117149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-24 [patent_title] => 'Carbon nanotube binding peptides' [patent_app_type] => utility [patent_app_number] => 11/352782 [patent_app_country] => US [patent_app_date] => 2006-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10925 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20070117149.pdf [firstpage_image] =>[orig_patent_app_number] => 11352782 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/352782
Carbon nanotube binding peptides Feb 12, 2006 Abandoned
Array ( [id] => 4727961 [patent_doc_number] => 20080207505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Bna Conjugates and Methods of Use' [patent_app_type] => utility [patent_app_number] => 11/813830 [patent_app_country] => US [patent_app_date] => 2006-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 37317 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207505.pdf [firstpage_image] =>[orig_patent_app_number] => 11813830 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/813830
Bna Conjugates and Methods of Use Jan 11, 2006 Abandoned
Array ( [id] => 4898873 [patent_doc_number] => 20080118487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-22 [patent_title] => 'Myostatin Isoform' [patent_app_type] => utility [patent_app_number] => 11/576449 [patent_app_country] => US [patent_app_date] => 2005-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 23987 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 32 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20080118487.pdf [firstpage_image] =>[orig_patent_app_number] => 11576449 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/576449
Myostatin Isoform Sep 29, 2005 Abandoned
Array ( [id] => 5242830 [patent_doc_number] => 20070021325 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Drug formulation containing a solubilizer for enhancing solubility, absorption, and permeability' [patent_app_type] => utility [patent_app_number] => 11/188217 [patent_app_country] => US [patent_app_date] => 2005-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4204 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20070021325.pdf [firstpage_image] =>[orig_patent_app_number] => 11188217 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/188217
Drug formulation containing a solubilizer for enhancing solubility, absorption, and permeability Jul 20, 2005 Abandoned
Array ( [id] => 5119406 [patent_doc_number] => 20070141120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Peptide having an ace inhibiting effect' [patent_app_type] => utility [patent_app_number] => 10/582759 [patent_app_country] => US [patent_app_date] => 2004-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4632 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20070141120.pdf [firstpage_image] =>[orig_patent_app_number] => 10582759 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/582759
Peptide having an ace inhibiting effect Nov 18, 2004 Abandoned
Array ( [id] => 7360143 [patent_doc_number] => 20040250301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Transgenic animals' [patent_app_type] => new [patent_app_number] => 10/639754 [patent_app_country] => US [patent_app_date] => 2003-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9241 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20040250301.pdf [firstpage_image] =>[orig_patent_app_number] => 10639754 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/639754
Transgenic animals Aug 12, 2003 Abandoned
Array ( [id] => 7397217 [patent_doc_number] => 20040038878 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Injectable protein formulations' [patent_app_type] => new [patent_app_number] => 10/343487 [patent_app_country] => US [patent_app_date] => 2003-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5632 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20040038878.pdf [firstpage_image] =>[orig_patent_app_number] => 10343487 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/343487
Injectable protein formulations Jan 30, 2003 Abandoned
Array ( [id] => 6830313 [patent_doc_number] => 20030181371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Compositions and methods of using collajolie' [patent_app_type] => new [patent_app_number] => 10/331125 [patent_app_country] => US [patent_app_date] => 2002-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18839 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20030181371.pdf [firstpage_image] =>[orig_patent_app_number] => 10331125 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/331125
Compositions and methods of using collajolie Dec 26, 2002 Abandoned
Array ( [id] => 6653071 [patent_doc_number] => 20030105301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Separation of glyco-containing entities' [patent_app_type] => new [patent_app_number] => 10/275319 [patent_app_country] => US [patent_app_date] => 2002-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4756 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20030105301.pdf [firstpage_image] =>[orig_patent_app_number] => 10275319 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/275319
Separation of glyco-containing entities Nov 4, 2002 Abandoned
Array ( [id] => 6556047 [patent_doc_number] => 20020111496 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-15 [patent_title] => 'Inhibitors of glycosyltransferase enzymes' [patent_app_type] => new [patent_app_number] => 10/067495 [patent_app_country] => US [patent_app_date] => 2002-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3443 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20020111496.pdf [firstpage_image] =>[orig_patent_app_number] => 10067495 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/067495
Inhibitors of glycosyltransferase enzymes Feb 3, 2002 Abandoned
Array ( [id] => 7127830 [patent_doc_number] => 20050059574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Compositions of stable T3 and methodes of use thereof' [patent_app_type] => utility [patent_app_number] => 09/998346 [patent_app_country] => US [patent_app_date] => 2001-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 6372 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 09998346 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/998346
Compositions of stable T3 and methodes of use thereof Nov 29, 2001 Abandoned
Array ( [id] => 4010536 [patent_doc_number] => 05962477 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'Screening methods for cytokine inhibitors' [patent_app_type] => 1 [patent_app_number] => 9/097441 [patent_app_country] => US [patent_app_date] => 1998-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 46225 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/962/05962477.pdf [firstpage_image] =>[orig_patent_app_number] => 097441 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/097441
Screening methods for cytokine inhibitors Jun 14, 1998 Issued
Array ( [id] => 3943440 [patent_doc_number] => 05955057 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'Effervescing or foaming bath shape or solid' [patent_app_type] => 1 [patent_app_number] => 9/096517 [patent_app_country] => US [patent_app_date] => 1998-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3681 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955057.pdf [firstpage_image] =>[orig_patent_app_number] => 096517 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/096517
Effervescing or foaming bath shape or solid Jun 11, 1998 Issued
Array ( [id] => 3939327 [patent_doc_number] => 05981479 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Cyclosporins' [patent_app_type] => 1 [patent_app_number] => 9/084709 [patent_app_country] => US [patent_app_date] => 1998-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7104 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/981/05981479.pdf [firstpage_image] =>[orig_patent_app_number] => 084709 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/084709
Cyclosporins May 25, 1998 Issued
Array ( [id] => 3951678 [patent_doc_number] => 05955572 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'Structural mimics of RGD-binding sites' [patent_app_type] => 1 [patent_app_number] => 9/079432 [patent_app_country] => US [patent_app_date] => 1998-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 10498 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955572.pdf [firstpage_image] =>[orig_patent_app_number] => 079432 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/079432
Structural mimics of RGD-binding sites May 13, 1998 Issued
Array ( [id] => 4048368 [patent_doc_number] => 05968903 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'Inhibition of H. pylori proliferation' [patent_app_type] => 1 [patent_app_number] => 9/074117 [patent_app_country] => US [patent_app_date] => 1998-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10469 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/968/05968903.pdf [firstpage_image] =>[orig_patent_app_number] => 074117 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/074117
Inhibition of H. pylori proliferation May 6, 1998 Issued
Array ( [id] => 3945560 [patent_doc_number] => 05977067 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'Cyclosporin derivatives, their preparation and the pharmaceutical compositions which contain them' [patent_app_type] => 1 [patent_app_number] => 9/069959 [patent_app_country] => US [patent_app_date] => 1998-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17492 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/977/05977067.pdf [firstpage_image] =>[orig_patent_app_number] => 069959 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/069959
Cyclosporin derivatives, their preparation and the pharmaceutical compositions which contain them Apr 29, 1998 Issued
Menu